Millennium Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
Millennium Management's CCCC Position: Q3 2026 in Review
Millennium Management increased its C4 Therapeutics (CCCC) stake by 24% in Q3 2026, buying an estimated $190K and bringing the position to 266,432 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #4568.
Millennium Management first reported a position in CCCC in Q4 2020 and has held it in 22 quarters since. The position peaked at $24.3M in Q4 2021. 152 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- Millennium Management held 266,432 shares of C4 Therapeutics worth $887K as of Q3 2026.
- Millennium Management bought 51,046 C4 Therapeutics shares in Q3 2026, an estimated $190K.
- C4 Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4568 holding.
- Millennium Management first reported a position in C4 Therapeutics in Q4 2020 and has held it in 22 quarters since.
- Millennium Management's C4 Therapeutics position peaked at $24.3M in Q4 2021.
- 152 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.